Literature DB >> 2587210

Primary structure differences between proteins C1 and C2 of HeLa 40S nuclear ribonucleoprotein particles.

B M Merrill1, S F Barnett, W M LeStourgeon, K R Williams.   

Abstract

Partial acid cleavage, comparative HPLC tryptic peptide mapping and amino acid sequencing of the C1 and C2 proteins of HeLa heterogeneous nuclear ribonucleoprotein (hnRNP) particles demonstrate that proteins C1 and C2 differ in primary structure by the presence of a 13 amino acid insert sequence in C2. This C2 insert sequence occurs after either glycine 106 or serine 107 in C1. The additional 13 amino acids that are present in C2 account for the observed molecular weight difference between the C1 and C2 hnRNP proteins on SDS polyacrylamide gel electrophoresis. Because C1 and C2 appear identical except for the 13 residue insert and because the 3' and 5' untranslated regions of the corresponding mRNAs also appear to be the same (Swanson et al., Mol. Cell. Biol. 7: 1731-1739), it is possible that both polypeptides are produced from a single transcription unit through an alternative splicing mechanism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587210      PMCID: PMC335017          DOI: 10.1093/nar/17.21.8441

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

1.  Two endogenous protein kinase activities in heterogeneous nuclear ribonucleoprotein particles (hnRNP).

Authors:  C W McGregor; J T Knowler
Journal:  Mol Biol Rep       Date:  1987       Impact factor: 2.316

2.  Splicing of messenger RNA precursors.

Authors:  P A Sharp
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

3.  Heterogeneous nuclear ribonucleoproteins: role in RNA splicing.

Authors:  Y D Choi; P J Grabowski; P A Sharp; G Dreyfuss
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

Review 4.  Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes.

Authors:  R E Breitbart; A Andreadis; B Nadal-Ginard
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins.

Authors:  M S Swanson; T Y Nakagawa; K LeVan; G Dreyfuss
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

6.  Nuclear protein phosphorylation in isolated nuclei from HeLa cells. Evidence that 32P incorporation from [gamma-32P]GTP is catalyzed by nuclear kinase II.

Authors:  D L Friedman; N J Kleiman; F E Campbell
Journal:  Biochim Biophys Acta       Date:  1985-11-20

7.  Site specificity of casein kinase-2 (TS) from rat liver cytosol. A study with model peptide substrates.

Authors:  O Marin; F Meggio; F Marchiori; G Borin; L A Pinna
Journal:  Eur J Biochem       Date:  1986-10-15

8.  Synthetic peptides including acidic clusters as substrates and inhibitors of rat liver casein kinase TS (type-2).

Authors:  F Meggio; F Marchiori; G Borin; G Chessa; L A Pinna
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

9.  Phenylalanines that are conserved among several RNA-binding proteins form part of a nucleic acid-binding pocket in the A1 heterogeneous nuclear ribonucleoprotein.

Authors:  B M Merrill; K L Stone; F Cobianchi; S H Wilson; K R Williams
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

10.  The core proteins of 35S hnRNP complexes. Characterization of nine different species.

Authors:  H E Wilk; H Werr; D Friedrich; H H Kiltz; K P Schäfer
Journal:  Eur J Biochem       Date:  1985-01-02
View more
  21 in total

1.  A uridylate tract mediates efficient heterogeneous nuclear ribonucleoprotein C protein-RNA cross-linking and functionally substitutes for the downstream element of the polyadenylation signal.

Authors:  J Wilusz; T Shenk
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

Review 2.  Heterogeneous nuclear ribonucleoprotein complexes.

Authors:  M S Swanson
Journal:  Mol Biol Rep       Date:  1990       Impact factor: 2.316

3.  The core proteins A2 and B1 exist as (A2)3B1 tetramers in 40S nuclear ribonucleoprotein particles.

Authors:  S F Barnett; T A Theiry; W M LeStourgeon
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

4.  Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.

Authors:  Yuan Shen; Shanshan Liu; Jiao Fan; Yinghua Jin; Baolei Tian; Xiaofei Zheng; Hanjiang Fu
Journal:  EMBO Rep       Date:  2017-03-06       Impact factor: 8.807

5.  hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability.

Authors:  D J Williamson; S Banik-Maiti; J DeGregori; H E Ruley
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  Tobacco nuclear gene for the 31 kd chloroplast ribonucleoprotein: genomic organization, sequence analysis and expression.

Authors:  Y Q Li; L Z Ye; M Sugita; M Sugiura
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

Review 7.  Hormone response element binding proteins: novel regulators of vitamin D and estrogen signaling.

Authors:  Thomas S Lisse; Martin Hewison; John S Adams
Journal:  Steroids       Date:  2011-01-13       Impact factor: 2.668

8.  The Rb97D gene encodes a potential RNA-binding protein required for spermatogenesis in Drosophila.

Authors:  I Karsch-Mizrachi; S R Haynes
Journal:  Nucleic Acids Res       Date:  1993-05-11       Impact factor: 16.971

Review 9.  Vitamin D and alternative splicing of RNA.

Authors:  Rui Zhou; Rene F Chun; Thomas S Lisse; Alejandro J Garcia; Jianzhong Xu; John S Adams; Martin Hewison
Journal:  J Steroid Biochem Mol Biol       Date:  2014-10-16       Impact factor: 4.292

10.  The Drosophila Hrb87F gene encodes a new member of the A and B hnRNP protein group.

Authors:  S R Haynes; D Johnson; G Raychaudhuri; A L Beyer
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.